This panel will identify successful strategies that underpin currently-marketed therapies and examine how establishing a framework early in development helps keep long-term production and commercialization goals on track.
Matthew Durdy, Chief Executive Officer
Panel: The Importance Of Early Planning In Cell & Gene Therapy Commercialization
- Jeffrey Hung, Chief Commercial Officer – Vigene Biosciences
- Shesh Sharma, Sr. Director, Clinical Stage CAR-T – Innolynx
- Matthew Durdy, Chief Executive Officer - Cell and Gene Therapy Catapult
- Timothy P. Bradshaw, Executive Director, Center of Global Drug Development – PRA
Wednesday 25 August, 15:00 BST